Medical Economics January 20, 2025
Key Takeaways
- GLP-1 receptor agonists show significant benefits for neurological and behavioral health, reducing risks of addiction and neurocognitive disorders.
- These drugs modestly reduce cardiovascular risks, with benefits ranging from a 10% to 20% reduction in heart attack and stroke risks.
- Potential risks include gastrointestinal issues, pancreatitis, and kidney problems, necessitating vigilant monitoring by healthcare providers.
- Comprehensive evaluation of GLP-1RA drugs’ effects across all body systems is crucial to balance their benefits and risks in clinical practice.
Surge in GLP-1RA use has researchers looking at all benefits of the drugs, but also the risk to the pancreas and kidneys
The popularity of weight-loss medications such as Ozempic and Wegovy continues to soar, with a new study reporting that...
Today's Sponsors
Today's Sponsor